Ironwood Pharmaceuticals Inc (IRWD)

Exchange
NASDAQ
Symbol
IRWD
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
Country
USA

Stock price

At close: November 6, 2024

  • Open
    4.91
  • High
    5.05
  • Low
    4.74
  • Close
    5.04
  • Volume
    3,115,720

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
—
Receivables turnover
3.33
Payables turnover
20.30
Working capital turnover
—
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
109.72
Number of days of payables
17.98
Fixed asset turnover
76.91
Total asset turnover
0.91
 Liquidity ratios
Current ratio
0.84
Quick ratio
0.80
Cash ratio
0.33
Cash conversion cycle
91.74
 Solvency ratios
Debt-to-assets ratio
1.06
Debt-to-capital ratio
3.28
Debt-to-equity ratio
—
Financial leverage ratio
—
Interest coverage
-41.48
 Profitability ratios
Gross profit margin
72.15%
Operating profit margin
-220.10%
Pretax margin
-213.89%
Net profit margin
-233.32%
Operating return on assets (Operating ROA)
-200.70%
Return on assets (ROA)
-212.76%
Return on total capital
-590.16%
Return on equity (ROE)
—